Literature DB >> 22322528

Relative deficiency of acidic isoforms of osteopontin from stone former urine.

A M Kolbach1, O Afzal, B Halligan, E Sorokina, J G Kleinman, J A Wesson.   

Abstract

We have tested the relative electrophoretic mobility of osteopontin (OPN) isolated from urine obtained from normal individuals (NU) against similar samples derived from the urine of stone formers (SFU) using high-resolution isoelectric focusing (isoelectric point, pI range 3.5-4.5) in 2D electrophoresis, with Western blot detection. We also report the results from competitive ELISA analyses of these samples. We demonstrated that human urinary OPN has a discrete four band separation pattern that conforms to four previously documented OPN isoforms. The lower two M(r) isoforms migrate to a greater degree toward the acidic end of the gel than do the higher two M(r) isoforms. Densitometry of the signal reveals significant difference in the migration pattern of OPN from SFU as compared to that from NU based on an analysis of the spot intensities grouped in 0.1 pI unit increments. A novel method for the calculation of a weight-averaged pI based on the relative signal strength in an OPN 2D Western blot was developed. The analysis revealed a significantly increased weight-averaged pI values for the higher M(r) forms of OPN in the stone former compared to normal population. Additionally, alkaline phosphatase-treated NU samples resulted in a significant average pI shift of 0.05 units in the alkaline direction, suggesting that a decrease in the average degree of phosphorylation could be responsible for the difference between NU and SFU pI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322528      PMCID: PMC4978133          DOI: 10.1007/s00240-012-0459-1

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  34 in total

1.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.

Authors:  H Shiraga; W Min; W J VanDusen; M D Clayman; D Miner; C H Terrell; J R Sherbotie; J W Foreman; C Przysiecki; E G Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

2.  Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.

Authors:  S Razzouk; J C Brunn; C Qin; C E Tye; H A Goldberg; W T Butler
Journal:  Bone       Date:  2002-01       Impact factor: 4.398

3.  Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals.

Authors:  J R Hoyer; J R Asplin; L Otvos
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

4.  Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm-Horsfall glycoprotein in hypertensive and hyperoxaluric patients.

Authors:  Kamalanathan Sumitra; Viswanathan Pragasam; Ramasamy Sakthivel; Periandavan Kalaiselvi; Palaninathan Varalakshmi
Journal:  Nephrol Dial Transplant       Date:  2005-04-26       Impact factor: 5.992

Review 5.  Osteopontin and calcium stone formation.

Authors:  Jack G Kleinman; Jeffrey A Wesson; Jeremy Hughes
Journal:  Nephron Physiol       Date:  2004

6.  Mechanism of formation of human calcium oxalate renal stones on Randall's plaque.

Authors:  Andrew P Evan; Fredric L Coe; James E Lingeman; Youzhi Shao; Andre J Sommer; Sharon B Bledsoe; Jennifer C Anderson; Elaine M Worcester
Journal:  Anat Rec (Hoboken)       Date:  2007-10       Impact factor: 2.064

Review 7.  Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.

Authors:  Christian C Kazanecki; Dana J Uzwiak; David T Denhardt
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

8.  Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning.

Authors:  Yung-Ching Chien; David L Masica; Jeffrey J Gray; Sarah Nguyen; Hojatollah Vali; Marc D McKee
Journal:  J Biol Chem       Date:  2009-07-06       Impact factor: 5.157

9.  Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell.

Authors:  T Yamate; K Kohri; T Umekawa; M Iguchi; T Kurita
Journal:  J Urol       Date:  1998-10       Impact factor: 7.450

10.  Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.

Authors:  Jeffrey A Wesson; Richard J Johnson; Marrilda Mazzali; Anne M Beshensky; Susan Stietz; Ceci Giachelli; Lucy Liaw; Charles E Alpers; William G Couser; Jack G Kleinman; Jeremy Hughes
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  10 in total

1.  Guaifenesin stone matrix proteomics: a protocol for identifying proteins critical to stone formation.

Authors:  A M Kolbach-Mandel; N S Mandel; S R Cohen; J G Kleinman; F Ahmed; I C Mandel; J A Wesson
Journal:  Urolithiasis       Date:  2016-07-19       Impact factor: 3.436

2.  Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.

Authors:  W G Robertson
Journal:  Urolithiasis       Date:  2014-11-20       Impact factor: 3.436

3.  Biomimetic Randall's plaque as an in vitro model system for studying the role of acidic biopolymers in idiopathic stone formation.

Authors:  Archana Chidambaram; Douglas Rodriguez; Saeed Khan; Laurie Gower
Journal:  Urolithiasis       Date:  2014-08-15       Impact factor: 3.436

Review 4.  From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis.

Authors:  Johannes M Baumann; Beat Affolter
Journal:  World J Nephrol       Date:  2014-11-06

5.  Development of a two-stage in vitro model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 1-biomimetic Randall's plaque using decellularized porcine kidneys.

Authors:  Archana C Lovett; Saeed R Khan; Laurie B Gower
Journal:  Urolithiasis       Date:  2018-05-18       Impact factor: 3.436

6.  Alteration of urinary macromolecules by adsorption on surfaces, probably an important factor in urolithiasis.

Authors:  J M Baumann; B Affolter; U von Arx; M Noël
Journal:  Urolithiasis       Date:  2013-09-14       Impact factor: 3.436

Review 7.  Roles of osteopontin gene polymorphism (rs1126616), osteopontin levels in urine and serum, and the risk of urolithiasis: a meta-analysis.

Authors:  Xiao Li; Kang Liu; Yongsheng Pan; Jing Zhang; Qiang Lv; Lixin Hua; Zengjun Wang; Jie Li; Changjun Yin
Journal:  Biomed Res Int       Date:  2015-02-15       Impact factor: 3.411

8.  The paradoxical role of urinary macromolecules in the aggregation of calcium oxalate: a further plea to increase diuresis in stone metaphylaxis.

Authors:  J M Baumann; B Affolter
Journal:  Urolithiasis       Date:  2016-02-26       Impact factor: 3.436

9.  An antibody-free sample pretreatment method for osteopontin combined with MALDI-TOF MS/MS analysis.

Authors:  Yuye Zhou; Joakim Romson; Åsa Emmer
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

Review 10.  Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight.

Authors:  Anne-Sophie Lamort; Ioanna Giopanou; Ioannis Psallidas; Georgios T Stathopoulos
Journal:  Cells       Date:  2019-08-02       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.